换一批Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study.
第一作者：
J,Bousquet
第一单位：
MACVIA-LR, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.;INSERM, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, U1168 Paris, and UVSQ, UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Yvelines, France.
作者：
J,Bousquet [1]
;
D P,Caimmi [2]
;
A,Bedbrook [3]
;
M,Bewick [4]
;
P W,Hellings [5]
;
P,Devillier [6]
;
S,Arnavielhe [7]
;
C,Bachert [8]
;
K C,Bergmann [9]
;
G W,Canonica [10]
;
N H,Chavannes [11]
;
A A,Cruz [12]
;
R,Dahl [12]
;
P,Demoly [2]
;
G,De Vries [13]
;
E,Mathieu-Dupas [7]
;
A,Finkwagner [14]
;
J,Fonseca [15]
;
N,Guldemond [16]
;
T,Haahtela [17]
;
B,Hellqvist-Dahl [18]
;
J,Just [19]
;
T,Keil [20]
;
L,Klimek [21]
;
M L,Kowalski [22]
;
M,Kuitunen [23]
;
P,Kuna [24]
;
V,Kvedariene [25]
;
D,Laune [7]
;
A M,Pereira [15]
;
P,Carreiro-Martins [26]
;
E,Melén [27]
;
M,Morais-Almeida [28]
;
J,Mullol [29]
;
A,Muraro [30]
;
R,Murray [31]
;
L,Nogueira-Silva [32]
;
N G,Papadopoulos [33]
;
G,Passalacqua [10]
;
F,Portejoie [3]
;
D,Price [34]
;
D,Ryan [35]
;
B,Samolinski [36]
;
A,Sheikh [37]
;
V,Siroux [38]
;
O,Spranger [14]
;
A,Todo Bom [39]
;
P V,Tomazic [40]
;
A,Valero [41]
;
E,Valovirta [42]
;
A,Valiulis [43]
;
O,VandenPlas [44]
;
S,van der Meulen [45]
;
M,van Eerd [13]
;
M,Wickman [27]
;
T,Zuberbier [9]
作者单位：
MACVIA-LR, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.;INSERM, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, U1168 Paris, and UVSQ, UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Yvelines, France.
[1]
CHRU de Montpellier, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, Sorbonne Universités, Paris, France.;Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
[2]
MACVIA-LR, Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon, European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
[3]
iQ4U Consultants Ltd, London, UK.
[4]
Department of Microbiology and Immunology, Laboratory of Clinical Immunology, KU Leuven, Leuven, Belgium.
[5]
Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, Versailles, France.
[6]
Kyomed, Montpellier, France.
[7]
ENT Department, Upper Airways Research Laboratory, Ghent University Hospital, Ghent, Belgium.
[8]
Department of Dermatology and Allergy, Comprehensive Allergy-Centre-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.;Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
[9]
Allergy and Respiratory Diseases Clinic, DIMI, University of Genoa, IRCCS AOU San Martino-IST, Genoa, Italy.
[10]
Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
[11]
ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brasil.;GARD Executive Committee, Geneva, Switzerland.
[12]
Peercode BV, Gerdermalsen, The Netherlands.
[13]
Global Allergy and Asthma Platform GAAPP, Vienna, Austria.
[14]
Center for Health Technology and Services Research - CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.;Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal.
[15]
Institute of Health Policy and Management iBMG - Erasmus Universit, Rotterdam, The Netherlands.
[16]
Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
[17]
Department of Respiratory Diseases, Odense University Hospital, Odense, Denmark.
[18]
Allergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Sorbonne Universités, Paris, France.
[19]
Institute of Social Medicine, Epidemiology and Health Economics, Charité -Universitätsmedizin Berlin, Berlin, Germany.;Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
[20]
Center for Rhinology and Allergology, Wiesbaden, Germany.
[21]
Department of Immunology, Rheumatology and Allergy, Healthy Ageing Reseach Centre (HARC), Medical University of Lodz, Lodz, Poland.
[22]
Children's Hospital, University of Helsinki and University Hospital of Helsinki, Helsinki, Finland.
[23]
Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
[24]
Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
[25]
CEDOC, Respiratory Research Group, Nova Medical School, Campo dos Martires da Patria, Lisbon, Portugal.;Serviço de Imunoalergologia, Hospital de Dona Estefânia, Centro Hospitalar de Lisboa Central, EPE, Lisbon, Portugal.
[26]
Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.;Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
[27]
Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisboa, Portugal.
[28]
ENT Department, Hospital Clinic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, Universitat de Barcelona, Barcelona, Catalonia, Spain.
[29]
Department of Women and Child Health, Food Allergy Referral Centre Veneto Region, Padua General University Hospital, Padua, Italy.
[30]
Medical Communications Consultant, MedScript Ltd, Dundalk, Co Louth, Ireland.
[31]
Center for Health Technology and Services Research - CINTESIS, Porto, Portugal.;Department of Internal Medicine, Centro Hospitalar Sao Joao, Porto, Portugal.
[32]
Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.;Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
[33]
Observational and Pragmatic Research Institute, Singapore and Academic Centre of Primary Care, University of Aberdeen, Aberdeen, UK.
[34]
Honorary Clinical Research Fellow, Allergy and Respiratory Research Group, The University of Edinburgh, Edinburgh, UK.
[35]
Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
[36]
Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
[37]
INSERM, Université Grenoble Alpes, IAB, U 1209, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Université Joseph Fourier, Grenoble, France.
[38]
Imunoalergologia, Centro Hospitalar Universitario de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
[39]
Medical University of Graz, ENT University Hospital Graz, Graz, Austria.
[40]
Pneumology and Allergy Department, CIBERES and Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
[41]
Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland.;Department of Allergy Clinic, Terveystalo, Turku, Finland.
[42]
Vilnius University Clinic of Children's Diseases and Public Health Institute, Vilnius, Lithuania.;European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
[43]
Department of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.
[44]
Attorney at law, Axon Lawyers, the Netherlands. Role: provision of legal services.
[45]
DOI
10.1111/all.13125
PMID
28072463
发布时间
2025-05-30
- 浏览12
Allergy
Allergy
857-865页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
